Tandem Diabetes Care, Inc. Income (Loss) Attributable to Parent, before Tax
Tandem Diabetes Care, Inc. (TNDM) reported Income (Loss) Attributable to Parent, before Tax of -$14.77 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2020-04-30
- Tandem Diabetes Care, Inc. income (loss) attributable to parent, before tax for the quarter ending 2020-03-31 was -$14.77M.
- Tandem Diabetes Care, Inc. income (loss) attributable to parent, before tax for the quarter ending 2019-09-30 was -$2.83M.
- Tandem Diabetes Care, Inc. income (loss) attributable to parent, before tax for the quarter ending 2019-03-31 was -$22.99M.
- Tandem Diabetes Care, Inc. income (loss) attributable to parent, before tax for the quarter ending 2018-09-30 was -$34.24M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 9 month |
|---|---|---|
| 2020-03-31 | -$14.77M 10-Q · filed 2020-04-30 | |
| 2019-09-30 | -$2.83M 10-Q · filed 2019-11-04 | -$27.33M 10-Q · filed 2019-11-04 |
| 2019-03-31 | -$22.99M 10-Q · filed 2020-04-30 | |
| 2018-09-30 | -$34.24M 10-Q · filed 2019-11-04 | -$126.30M 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |